Abstract
Purpose
The aim of this prospective descriptive study was to evaluate the efficacy of reducing sexual abstinence as a strategy to decrease sperm DNA fragmentation.
Methods
Men with one or more of the following characteristics were included in the study: older than 44, smoking more than 10 cigarettes per day, with a body mass index over 25, diabetes mellitus, varicocele, a previous chemotherapy treatment, severe oligozoospermia, prostatitis, cryptorchidism, having a partner with recurrent miscarriage and/or implantation failure, poor embryo morphology and/or fertilization failure. Patients were asked to produce a semen sample after 3 to 7 abstinence days which was subjected to a sperm DNA fragmentation test. When DNA fragmentation was above or equal to 30 %, it was considered to be altered. Patients with increased DNA fragmentation were asked to produce another semen sample following a “one abstinence day protocol”. This protocol required producing up to three semen samples with 1 day of abstinence and measuring sperm DNA fragmentation.
Results
Four hundred and sixteen patients produced a first semen sample after a sexual abstinence of 3 to 7 days. Sperm DNA fragmentation was altered in 46 samples (11.1 %). Thirty five patients with increased DNA fragmentation samples completed the “one abstinence day protocol”. DNA fragmentation decreased to normal values in one of the three attempts in 91.4 % of the patients: 81.3 % in the first attempt, 12.5 % in the second try and 6.3 % in the third.
Conclusions
This approach could be a simple, low-cost and effective way to decrease sperm DNA damage to normal values.
Similar content being viewed by others
References
Sun J-G, Jurisicova A, Casper RF. Detection of deoxyribonucleic acid fragmentation in human sperm: correlation with fertilization in vitro. Biol Reprod. 1997;56:602–7.
Alvarez JG, Sharma Rakesh K, Ollero M, Saleh Ramadan A, Lopez MC, Thomas Jr AJ, et al. Increased DNA damage in sperm from leukocytospermic semen samples as determined by the sperm chromatin structure assay. Fertil Steril. 2002;78:319–28.
Wyrobek AJ, Eskenazi B, Young S, Arnheim N, Tiemann-Boege I, Jabs EW, et al. Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci. 2006;103:9601–6.
Potts RJ, Newbury CJ, Smith G, Notarianni LJ, Jefferies TM. Sperm chromatin damage associated with male smoking. Mutat Res. 1999;423:103–4.
Viloria T, Garrido N, Fernández JL, Remohí J, Pellicer A, Meseguer M. Sperm selection by swim-up in terms of deoxyribonucleic acid fragmentation as measured by the sperm chromatin dispersion test is altered in heavy smokers. Fertil Steril. 2007;88:523–5.
Saleh RA, Agarwal A, Sharma RK, Said TM, Sikka SC, Thomas Jr AJ. Evaluation of nuclear DNA damage in spermaozoa from infertile men with varicocele. Fertil Steril. 2003;80:1431–6.
Chi-huang C, Shang-sen l, Da-chang C, Hsin-hsuan C, I-ching C, Yung-ning C, et al. Apoptosis and Kinematics of ejaculated spermatozoa in patients with varicocele. J Androl. 2004;25:348–53.
Enciso M, Muriel l, Fernández JL, Goyanes V, Segrelles E, Marcos M, et al. Infertile men with varicocele show a high relative proportion of sperm cells with intense nuclear damage level, evidenced by the sperm chromatin dispersion test. J Androl. 2006;27:106–11.
Robaire B, Hales BF. Mechanisms of action of cyclophosphamide as a male-mediated developmental toxicant. Adv Exp Med Biol. 2003;518:169–80.
Agbaje IM, Rogers DA, McVicar CM, McClure N, Atkinson AB, Mallidis C, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod. 2007;7:1871–7.
Kort HI, Massey JB, Carlene WE, Mitchell-Leef D, Shapiro DB, Witt MA, et al. Impact os body mass index values on sperm quantity and quality. J Androl. 2006;27:450–2.
Banks S, King SA, Irvine SD, Saunders TKP. Impact of a mild scrotal heat stress on DNA integrity in murine spermatozoa. Reproduction. 2005;129:505–14.
Gallegos G, Ramos B, Santiso R, Goyanes V, Gosalvez J. Sperm DNA fragmentation in infertile men with genitourinary infection by Chlamydia trachomatis and Micoplasma. Fertil Steril. 2008;90:328–34.
Saleh RA, Agarwal A, Kandirali E, Sharma RK, Thomas Jr AJ, Nada EA, et al. Leukocytospermia is associated with increased ROS production by human spermatozoa. Fertil Steril. 2002;78:1215–24.
Tomlinson MJ, White A, Barratt CLR, Bolton AE, Cooke ID. The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocites. Hum Reprod. 1992;4:517–22.
Irvine DS, Twigg JP, Gordon EL, Fulton N, Milne PA, Aitken RJ. DNA integrity in human spermatozoa: relationship with semen quality. J Androl. 2000;21:33–44.
Spanò M, Bonde JP, Hjøllund HI, Kolstad HA, Cordelli E, Leter G. Sperm chromatin damage impairs human fertility. Fertil Steril. 2000;73:43–50.
Zini A, Bielecki R, Phang D, Zenzes MT. Correlation between two marked sperm DNA integrity, DNA denaturation and DNA fragmentation, in fertile and infertile men. Fertil Steril. 2001;4:674–7.
Zini A, Fischer MA, Sharir S, Shayegan B, Phang D, Jarvi K. Prevalence of abnormal sperm DNA denaturation in fertile and infertile men. Urology. 2002;60:1069–72.
Loft S, Kold-Jensen T, Hjollund NH, Giwercman A, Jesper Gyllemborg J, Ernst E, et al. Oxidative DNA damage in human sperm influences time to pregnancy. Hum Reprod. 2003;6:1265–72.
Duran EH, Morshedi M, Taylor S, Oehninger S. Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. Hum Reprod. 2002;12:3122–8.
Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J, et al. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod. 2007;1:174–9.
Muriel L, Garrido N, Fernández JL, Remohí J, Pellicer A, De los Santos MJ, et al. Value of the sperm deoxyribonucleic acid fragmentation level, as measured by the sperm chromatin dispersion test, in the outcome of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2006;85:371–83.
Velez de la Calle JP, Muller A, Walschaerts M, Clavere JL, Jiménez C, Wittemer C, et al. Sperm deoxyribonucleic acid fragmentation as assessed by sperm chromatin dispersion test in assisted reproductive technology programs: results of a large prospective multicenter study. Fertil Steril. 2008;90:1792–9.
Bungum M, Humaidan P, Spano M, Jepson K, Bungum L, Giwercman A. The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod. 2004;6:1401–8.
Larson KL, DeJonge CJ, Barnes AM, Jost LK, Evenson DP. Sperm chromatin structure assay parameters as predictors of failed pregnancy following assisted reproductive techniques. Hum Reprod. 2000;8:1717–22.
Zini A, Boman JM, Belzile E, Ciampi A. Sperm DNA damage is associated with an inceased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Hum Reprod. 2008;12:2663–8.
Fernández-González R, Nuno Moreira P, Pérez-Crespo M, Sánchez-Martín M, Ramirez MA, Pericuesta E, et al. Long-term effects of mouse intracytiplasmatic sperm injection with DNA-fragmented sperm on health and behavior of adult offspring. Biol Reprod. 2008;78:761–72.
Pérez-Crespo M, Moreira P, Pintado B, Gutiérrez-Adán A. Factors from damaged sperm affect its DNA integrity and its ability to promote embryo implantation in mice. J Androl. 2008;29:47–54.
Lewis SEM, Aitken RJ. DNA damage to spermatozoa has impacts on fertilization and pregnancy. Cell Tissue Res. 2005;322:33–41.
World Health Organization (WHO). Laboratory manual for the examination and processing of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: University Press; 1999.
Levitas E, Lunenfeld E, Weiss N, Friger M, Har-Vardi I, Koifman A, et al. Relationship between the duration of sexual abstinence and semen quality: analysis of 9,489 semen samples. Fertil Steril. 2005;83:1680–6.
Fernández JL, Muriel M, Rivero MT, Goyanes V, Vazquez R, Alvarez JG. The sperm chromatin dispersion test: a simple method for the determination of sperm DNA fragmentation. J Androl. 2003;24:59–66.
Spanò M, Kolstad AH, Larsen SB, Cordelli E, Leter G, Giwercman A, et al. The applicability of the flow cytometric sperm chromatin structute assay in epidemiological studies. Hum Reprod. 1998;9:2495–505.
Richthoff J, Spano M, Giwercman YL, Frohm B, Jepson K, Malm J, et al. The impact of testicular and accessory sex gland function on sperm chromatin integrity as assessed by the sperm chromatin structure assay (SCSA). Hum Reprod. 2002;12:3162–9.
Gosálvez J, González-Martinez M, López-Fernández C, Fernández JL, Sánchez-Martin P. Shorter abstinence decreases sperm deoxyribonucleic acid fragmentation in ejaculate. Fertil Steril. 2011;96:1083–6.
De Jonge C, LaFromboise M, Bosmans E, Pharm D, Ombelet W, Cox A, et al. Influence of the abstinence period on human sperm quality. Fertil Steril. 2004;82:57–65.
Seligman J, Kosower NS, Weissenberg R, Shalgi R. Thioldisulfide status of human sperm proteins. J Reprod Fertil. 1994;101:435–43.
Ollero M, Gil-Guzman E, Lopez MC, Sharma RK, Agarwal A, Larson K, et al. Characterizations of subsets of human spermatozoa at different stages of maturation: implications in the diagnosis and treatment of male infertility. Hum Reprod. 2001;9:1912–21.
Erenpreiss J, Bungum M, Spano M, Elzanaty S, Orbidans J, Giwercman A. Intra-individual variation in sperm chromatin structure assay parameters in men from infertile couples: clinical implications. Hum Reprod. 2006;8:2061–4.
Duru NK, Morshedi MS, Schuffner A, Oehninger S. Cryopreservation-thawing of fractionated human spermatozoa is associated with membrane phosphatidylserine externalization and Not DNA fragmentation. J Androl. 2001;22:646–51.
Agarwal A, Nallella KP, Allamaneni SR, Said TM. Role of antioxidants in treatment of male infertility: an overview of literature. Reprod Biomed Online. 2004;8:616–27.
Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl. 2005;26:349–53.
Greco E, Romano S, Iacobelli M, Ferrero S, Elena Baroni E, Minasi MG, et al. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Hum Reprod. 2005;9:2590–4.
Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. ANZJOG. 2007;47:216–21.
Tunc O, Thompson J, Tremellen K. Improvement in sperm DNA quality using an oral antioxidant therapy. Reprod Biomed Online. 2010;18:761–8.
Greco E, Scarselli F, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, et al. Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod. 2004;1:226–30.
Palermo GD, Cohen J, Alikani M, Adler A, Rosenwaks Z. Intracytoplasmic sperm injection: a novel treatment for all forms of male factor infertility. Fertil Steril. 1995;63:1231–40.
Said TM, Agarwal A, Zborowski M, Grunewald S, Glander H-J, Paasch U. Utility of magnetic cell separation as a molecular sperm preparation technique. J Androl. 2008;29:134–42.
Rawe VY, Boudria HU, Alvarez Sedóa C, Carroa M, Papiera S, Nodara F. Healthy baby born after reduction of sperm DNA fragmentation using cell sorting before ICSI. Reprod Biomed Online. 2010;20:320–3.
Parmegiani L, Cognigni GE, Bernardi S, Troilo E, Ciampaglia W, Filicori M. “Physiologic ICSI”: Hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril. 2010;93:598–604.
Practice Committee of the American Society for Reproductive Medicine. The clinical utility of sperm DNA integrity testing: a guideline. Fertil Steril. 2013;99:673–7.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule One abstinence day may be a simple, low cost and effective way to lower sperm DNA fragmentation to normal values.
Rights and permissions
About this article
Cite this article
Pons, I., Cercas, R., Villas, C. et al. One abstinence day decreases sperm DNA fragmentation in 90 % of selected patients. J Assist Reprod Genet 30, 1211–1218 (2013). https://doi.org/10.1007/s10815-013-0089-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-013-0089-8